Concepedia

Alison H. Foo

AH

Statistics

Publications

3

Citations

133

H-Index

3

Active since

2011

Affiliations

Queen Elizabeth II Health Sciences Centre(Current)

Princess Margaret Cancer Centre

University Health Network

Alison H. Foo is an author at Queen Elizabeth II Health Sciences Centre specializing in pharmacology, oncology pharmacotherapy, and medicine.

Publications per year

2011–2012

3

Publications

3

Brief Report: A Phase II Study of Sunitinib in Malignant Pleural Mesothelioma. The NCIC Clinical Trials Group

Scott A. Laurie, Ashish Gupta, Quincy S. Chu et al. · Journal of Thoracic Oncology · 2011 · 68 citations · Full text

, , +15

A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: trial IND.186

David MacDonald, Sarit Assouline, Joseph Brandwein et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2012 · 45 citations

, , +17

Sunitinib in relapsed or refractory diffuse large B-cell lymphoma: a clinical and pharmacodynamic phase II multicenter study of the NCIC Clinical Trials Group

Rena Buckstein, John Kuruvilla, Neil Chua et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2011 · 20 citations · Full text

, , +17

1–3 of 3